Successful Portfolios’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Sell
11,757
-948
-7% -$24.8K 0.13% 149
2026
Q1
$354K Sell
12,705
-847
-6% -$22.6K 0.2% 106
2025
Q4
$345K Buy
13,552
+312
+2% +$7.87K 0.18% 118
2025
Q3
$337K Sell
13,240
-505
-4% -$12.5K 0.2% 107
2025
Q2
$333K Buy
13,745
+10
+0.1% +$233 0.2% 101
2025
Q1
$348K Sell
13,735
-45
-0.3% -$1.18K 0.24% 88
2024
Q4
$366K Sell
13,780
-363
-3% -$9.85K 0.24% 82
2024
Q3
$409K Sell
14,143
-387
-3% -$11.3K 0.28% 79
2024
Q2
$407K Sell
14,530
-658
-4% -$18.1K 0.28% 74
2024
Q1
$421K Sell
15,188
-372
-2% -$10.3K 0.29% 79
2023
Q4
$448K Buy
15,560
+3,267
+27% +$98.8K 0.33% 69
2023
Q3
$408K Buy
12,293
+6
+0% +$212 0.36% 66
2023
Q2
$451K Sell
12,287
-1,585
-11% -$61.7K 0.39% 60
2023
Q1
$566K Sell
13,872
-546
-4% -$23.6K 0.36% 65
2022
Q4
$739K Buy
14,418
+4
+0% +$192 0.48% 55
2022
Q3
$631K Buy
14,414
+4
+0% +$194 0.46% 54
2022
Q2
$756K Sell
14,410
-334
-2% -$17K 0.51% 50
2022
Q1
$763K Buy
14,744
+60
+0.4% +$3.11K 0.43% 51
2021
Q4
$867K Buy
14,684
+158
+1% +$7.83K 0.47% 52
2021
Q3
$625K Buy
14,526
+2,109
+17% +$93.4K 0.37% 66
2021
Q2
$486K Buy
12,417
+69
+0.6% +$2.68K 0.29% 91
2021
Q1
$447K Buy
12,348
+35
+0.3% +$1.24K 0.29% 96
2020
Q4
$453K Sell
12,313
-547
-4% -$20.1K 0.33% 82
2020
Q3
$448K Buy
12,860
+559
+5% +$19.6K 0.36% 80
2020
Q2
$382K Buy
12,301
+506
+4% +$17.2K 0.34% 87
2020
Q1
$365K Buy
11,795
+577
+5% +$19.7K 0.37% 79
2019
Q4
$417K Buy
11,218
+460
+4% +$16.4K 0.37% 74
2019
Q3
$367K Buy
10,758
+1,312
+14% +$47.7K 0.34% 81
2019
Q2
$388K Sell
9,446
-462
-5% -$18.3K 0.42% 75
2019
Q1
$399K Sell
9,908
-467
-5% -$18.7K 0.44% 69
2018
Q4
$430K Sell
10,375
-6
-0.1% -$249 0.55% 56
2018
Q3
$434K Sell
10,381
-193
-2% -$7.43K 0.47% 63
2018
Q2
$364K Sell
10,574
-99
-0.9% -$3.38K 0.43% 77
2018
Q1
$359K Buy
10,673
+593
+6% +$20.4K 0.44% 75
2017
Q4
$346K Buy
+10,080
New +$344K 0.43% 78

Other funds holding PFE

Successful Portfolios's PFE Position: Q2 2026 in Review

Successful Portfolios reduced its Pfizer (PFE) stake by 7.5% in Q2 2026, selling an estimated $24.8K and leaving 11,757 shares worth $285K. The position accounts for 0.13% of the portfolio, ranked #149.

Successful Portfolios first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $867K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Successful Portfolios held 11,757 shares of Pfizer worth $285K as of Q2 2026.
  • Successful Portfolios sold 948 Pfizer shares in Q2 2026, an estimated $24.8K.
  • Pfizer made up 0.13% of Successful Portfolios's portfolio in Q2 2026, its #149 holding.
  • Successful Portfolios first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
  • Successful Portfolios's Pfizer position peaked at $867K in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Successful Portfolios's 13F filing for Q2 2026, filed 14 Jul 2026.